Gsk3 signalling and redox status in bipolar disorder: evidence from lithium efficacy
Together with observations that immune cells are in close physical contact with EEC (41), this led to the suggestion of an immunoendocrine axis and a critical role for EEC in orchestrating intestinal immune responses (42)
Tazuke speaks multiple languages, including Spanish, Mandarin and Japanese.
neurotypical children, and the association with autism severity
The germ, which contains the nucleic acids, polyphenols, flavonoids, vitamins, antioxidants, and other micronutrients
Heres the realistic timeline: Phase 3 trials (AMAZE program): - AMAZE 1 (obesity) started February 2026, enrolling ~1,150 participants - Primary completion estimated: June 2029 - Phase 3 in T2D also being planned following the ADA 2026 data US FDA approval (projected): Q4 2030 at the earliest (GlobalData estimate) EU EMA approval (projected): Q1 2031 at the earliest Bulgaria and Eastern Europe: Typically 612 months after EMA approval for market access, depending on national reimbursement negotiations
